Evaluation of plasma atherogenic index in patients with coronary slow flow phenomenon/Koroner yavas akim fenomeni olan hastalarda plazma aterojenik indeksinin incelenmesi

Purpose: Coronary slow flow phenomenon (CSFP) is considered a precursor of coronary artery disease (CAD) and associated with diffuse atherosclerosis, although its pathophysiology is still unclear. The atherogenic index of plasma (AIP) is associated with high cardiovascular risk. In this study, it is...

Full description

Saved in:
Bibliographic Details
Published in:Pamukkale Medical Journal 2022-07, Vol.15 (3), p.491
Main Authors: Adali, Mehmet Koray, Buber, Ipek, Turkoz, Anil, Til, Aysen
Format: Article
Language:English
Subjects:
Analysis
Angiography
Atherosclerosis
Cardiac patients
Care and treatment
Coronary heart disease
Low density lipoproteins
Medical records
Risk factors
Triglycerides
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: Coronary slow flow phenomenon (CSFP) is considered a precursor of coronary artery disease (CAD) and associated with diffuse atherosclerosis, although its pathophysiology is still unclear. The atherogenic index of plasma (AIP) is associated with high cardiovascular risk. In this study, it is aimed to investigate the relationship between AIP and CSFP. Material and method: Hospital records and coronary angiography (CAG) images of 214 patients with normal coronary arteries (NCA) and CSFP patients who underwent CAG between January 2019 and November 2021 have been retrospectively reviewed. Results: The patients were divided into two groups, CSFP (n=107) and NCA (n=107). The mean age was 59.3 years and 50.9% were male. Other demographic characteristics were similar between the two groups, except for gender distribution, age, frequency of HT, and smoking history. There was no difference in laboratory findings except glomerular filtration rate (GFR), serum creatinine level, LDL-C, HDL-C, non-HDL-C, and triglyceride levels. The AIP value was found high and statistically significant in patients with CSFP (p
ISSN:1309-9833
DOI:10.31362/patd.1091410